Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > If and only if

<< Previous

Bullboard Posts

Next >>

Comment by HouseSpeaker007on Jul 01, 2018 6:00pm

201 Views

Post# 28257694

RE:RE:If and only if

What you have to see is if the company is able to go further with the cash in hand. Where does the debate start? A) possible partner B) private placement C) bought deal By September it will come to fruition or reality if you persist. That is a how you play long. Need beer and steak money? Day trade

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1